SandsPoint Capital Advisors

SandsPoint Capital Advisors provides specialized resources and information for individuals managing type 2 diabetes, focusing on education and empowerment through practical tools and guidance. SandsPoint Capital Advisors, founded in 2012, is based in Irving, US. The company focuses on delivering essential support for individuals diagnosed with type 2 diabetes. It has completed a total of 1 deal, with the most recent deal occurring on August 15, 2022.

In that deal, SandsPoint Capital Advisors was acquired by Apex Group Ltd. , a portfolio company of Carlyle Group, Genstar Capital Partners, TA Associates, and Mubadala Investment Company. The financial terms of the acquisition were not disclosed. The company specializes in providing comprehensive resources and information tailored for individuals diagnosed with type 2 diabetes.

Their core offerings include educational materials that address the management of diabetes, such as guidance on daily living, coping strategies, and understanding insulin functions. Additionally, they offer tools like a glucose calculator and resources for reading food labels, which are essential for effective dietary management. These products are designed to empower end users—primarily newly diagnosed diabetics—by equipping them with knowledge to make informed decisions regarding their health. The services are available across various geographical markets, including urban and suburban regions in the United States, where there is a significant population of diabetes patients seeking support and information.

The company generates revenue through a combination of direct-to-consumer sales and partnerships with healthcare organizations. Their business model is structured around providing accessible information and tools that patients can utilize for diabetes management. Transactions typically occur as customers purchase educational resources or subscribe to ongoing support services. The pricing structure is designed to accommodate a wide range of users, from individuals seeking one-time resources to those in need of continuous assistance.

Specific flagship products, such as their glucose calculator and food label reading guides, are integral to their revenue generation strategy, appealing to the growing market of health-conscious consumers managing diabetes. Following the acquisition on August 15, 2022, SandsPoint Capital Advisors aims to enhance its offerings within the North American market as part of Apex Group Ltd. 's strategic growth initiatives. The company plans to expand its product line, introducing new educational materials and tools aimed at better assisting individuals with diabetes.

Additionally, SandsPoint Capital Advisors will explore opportunities for entering new geographic regions to serve a broader demographic of diabetes patients. The resources acquired through this partnership will enable SandsPoint Capital Advisors to deliver a comprehensive and high-quality service to all their client segments.